Facebook Twitter LinkedIn Google Plus RSS

Everett Laboratories acquires Quinnova Pharmaceuticals

By ,

Chatham-based Everett Laboraties Inc., a subsidiary of Spain-based Exeltis, announced Monday its acquisition of Quinnova Pharmaceuticals from Bridgewater-based Aneal Enterprises LLC. Terms of the deal were not disclosed.

According to the announcement, the acquisition will result in the strategic expansion of Everett into the fast-growing U.S. dermatology market. As a member of the Exeltis family, the acquisition will allow Quinnova to leverage extensive resources and capabilities in research and development, marketing strategy, intellectual property and business development worldwide. This broad-based support will enable Quinnova to be positioned to accelerate growth and development of its product portfolio and development pipeline.


Stay informed: Subscribe to free NJBIZ newsletters

 
 

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close